17 results
424B3
IKT
Inhibikase Therapeutics Inc
4 Apr 23
Prospectus supplement
4:57pm
in that country. Adverse pricing limitations may hinder our ability to recoup our investment in one or more product candidates, even if any product
POS AM
IKT
Inhibikase Therapeutics Inc
31 Mar 23
Prospectus update (post-effective amendment)
4:11pm
of the product in that country. Adverse pricing limitations may hinder our ability to recoup our investment in one or more product candidates, even
424B4
9rsp dp1umc
17 Jun 21
Prospectus supplement with pricing info
4:31pm
DRS
rh1oz2eea36jxs45
2 Jun 21
Draft registration statement
12:00am
10-K
szk wy1xrgfm
31 Mar 21
Annual report
2:14pm
424B4
zu61 r35r1
28 Dec 20
Prospectus supplement with pricing info
6:04am
S-1
tpxerqb 1c9gcn
23 Jul 20
IPO registration
12:28pm
DRS/A
55p824v 1y2y5
16 Oct 18
Draft registration statement (amended)
12:00am
- Prev
- 1
- Next